SCHEMBL5075969

SCHEMBL5075969

CCOC(=O)c1ccc(-c2[c]ccc(N(C)C)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
ALDH1A1 P00352 5/20 0.47
LMNA P02545 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SIRT2 Q8IXJ6 4/20 0.46
SIRT1 Q96EB6 3/20 0.46
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
GAA P10253 1/20 0.45
CYP1A2 P05177 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8531963 0.83 CA12 (0.50) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL8533452 0.80 PDGFRB (0.47) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL9324585 0.78 CA12 (0.48) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL10399338 0.77 RAB9A (0.44) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL9827926 0.77 ESR1 (0.52) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL15425 0.76 ALDH1A1 (0.70) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL5190217 0.76 ALDH1A1 (0.70) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL8531974 0.76 MAPT (0.52) MAPTNPC1RAB9AALDH1A1LMNA
Ammonia Solution, Strong SCHEMBL11211951 0.75 ALDH1A1 (0.68) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL8064164 0.75 ALDH1A1 (0.44) MAPTALDH1A1LMNASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007373-A2 INHIBITION OF ALPHA-SYNUCLEIN TOXICITY Foldrx Pharmaceuticals, Inc. (US) 2008-12-31 EP disclosed
WO-2007126841-A2 INHIBITION OF ALPHA-SYNUCLEIN TOXICITY FOLDRX PHARMACEUTICALS, INC. (US) 2007-11-08 WO disclosed